Column: Drugmaker AstraZeneca teaches Trump why the virus hunt can’t be rushed
4 years, 3 months ago

Column: Drugmaker AstraZeneca teaches Trump why the virus hunt can’t be rushed

LA Times  

Donald Trump’s effort to force science into serving his reelection campaign ran into a pothole Tuesday. These things take time, and one or two months to have all that happen seems not even feasible.” Trump’s preferred timeline assumes that the existing trials proceed perfectly. Those who defend Trump’s cheerleading for a vaccine sometimes argue that the public needs some good news in the pandemic these days — in other words, that Trump is feeding people good medicine. Business Column: Trump’s plotting for a pre-election vaccine carries real dangers for your health The Trump administration is plainly counting on a vaccine for COVID-19 becoming approved by the Nov. 3 election, in the expectation that news of the discovery will inspire a tide of public optimism that will sweep Trump to reelection. Quite the contrary: Trump’s overtly personal and partisan interest in an early vaccine approval has only served to destroy confidence that any approval coming before the election on Nov. 3 will be honestly earned.

Phase Approval Vaccine Moderna Astrazeneca Column Trump Phase 3 Phase 2 Pfizer Rna Public Need Drug Trials  teaches  vaccine  trumps  virus  approval  cant  phase  rushed  astrazeneca  public  need  drug  trials  drugmaker  hunt  column  trump

History of this topic

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
7 months, 2 weeks ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
7 months, 2 weeks ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
7 months, 2 weeks ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
7 months, 2 weeks ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca pulls its COVID-19 vaccine from the European market
7 months, 2 weeks ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
7 months, 2 weeks ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
7 months, 2 weeks ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

COVID-19 vaccines: Much ado about known unknowns
7 months, 2 weeks ago

COVID-19 vaccines: Much ado about known unknowns

The Hindu  

There are things we know that we don’t know. This risk was identified and flagged back in 2021; packaging was modified to insert information associated with the side effects; even the WHO wrote about it first in May 2021 and then in 2023.Read Bindu Shajan Perapaddan’s report on the rare vaccine side-effect is “no secret” and they are “well aware …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
7 months, 3 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

AstraZeneca admits its Covishield vaccine may lead to rare side effect
7 months, 3 weeks ago

AstraZeneca admits its Covishield vaccine may lead to rare side effect

New Indian Express  

As reported by The Telegraph, although AstraZeneca is disputing the allegations, it acknowledged in a legal filing submitted to the High Court in February that the vaccine "can, in very rare instances, lead to TTS." AstraZeneca, in a May 2023 response to Scott's lawyers, contested any direct link between the vaccine and TTS, stating they do not accept such a …

AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?
7 months, 3 weeks ago

AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?

Hindustan Times  

Pharmaceutical giant AstraZeneca has accepted for the first time that its Covid vaccine “can, in very rare cases, cause TTS”. {{^usCountry}} {{/usCountry}} AstraZeneca has been fighting a class action lawsuit that alleges its Covid vaccine, which was developed with the help of University of Oxford, has led to several deaths and serious injury. {{^userSubscribed}} {{/userSubscribed}} {{^userSubscribed}} {{/userSubscribed}} Responding to Scott's …

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab
1 year ago

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab

The Telegraph  

Iskra Reic, executive vice president of vaccines and immune therapies at AstraZeneca, said: “This aligns with our strategy to deliver a portfolio of therapies to address high unmet needs in infectious diseases, and our ambition to protect the most vulnerable patients who have high risk of severe outcomes.” Shares in AstraZeneca rose 1.3pc in afternoon trade on news of the …

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know
1 year, 1 month ago

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know

Daily Mail  

As Brits take AstraZeneca to court we recount what happened with the Covid jab AstraZeneca's Covid vaccine undoubtedly saved millions of lives. AstraZeneca's Covid jab timeline January 2020: Oxford University scientists start working on a Covid vaccine after the World Health Organization declares the spread of the virus a 'Public Health Emergency of International Concern' March 2020: Then Prime Minister …

The victims of AstraZeneca's vaccine
1 year, 7 months ago

The victims of AstraZeneca's vaccine

Daily Mail  

Jab complications were rare but the massive rollout saw dozens of Brits killed Covid vaccines are estimated to have saved millions of lives, by both protecting people from the virus and helping end the paralysing series of lockdowns. An inquest heard he was told there was no Pfizer jab in stock and was given out-of-date information in relation to blood …

High Hopes for Nasal Covid Vaccines Despite 'Disappointing' AstraZeneca Trial
2 years, 2 months ago

High Hopes for Nasal Covid Vaccines Despite 'Disappointing' AstraZeneca Trial

News 18  

Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite “disappointing” recent trial results for an AstraZeneca spray, experts say. Eric Tartour, an immunologist at the European Hospital Georges Pompidou in Paris, said that while the AstraZeneca results “are indeed disappointing”, he did not think the news “dampens hope for nasal vaccines”. However, the vaccine …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 2 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 7 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

EU regulator advises AstraZeneca’s COVID drug be cleared
2 years, 9 months ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press  

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

AstraZeneca set to abandon push for US vaccine approval
2 years, 9 months ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist
2 years, 10 months ago

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} An Oxford …

UK Marks First Anniversary of Oxford-AstraZeneca Covid-19 Vaccine Deployment
2 years, 11 months ago

UK Marks First Anniversary of Oxford-AstraZeneca Covid-19 Vaccine Deployment

News 18  

The UK's health service on Tuesday marked the first anniversary of the deployment of the Oxford/AstraZeneca vaccine against COVID-19, manufactured and deployed in India soon after as Covishield. "Backed by government funding, the UK-made Oxford-AstraZeneca vaccine has played an absolutely crucial role in our fight against COVID-19, saving countless lives in the UK and around the world," said UK Health …

COVID: Study suggests AstraZeneca booster works against Omicron
3 years ago

COVID: Study suggests AstraZeneca booster works against Omicron

Al Jazeera  

Findings from the study, which has yet to be peer reviewed, match those from Pfizer-BioNTech and Moderna. AstraZeneca has said that a third dose of its COVID-19 vaccine “significantly” lifted antibody levels against the Omicron coronavirus variant, citing data from a new laboratory study. Boosters ‘limit Omicron spread’ Oxford’s researchers analysed blood samples taken from individuals infected with COVID-19; those …

Mix and matching some COVID vaccines gives high immunity: Study
3 years ago

Mix and matching some COVID vaccines gives high immunity: Study

Al Jazeera  

Oxford University study finds mixing a first dose of the Pfizer or Astrazeneca vaccine with a second Moderna shot yields higher antibodies. “I think the data from this study will be especially interesting and valuable to low- and middle-income countries where they’re still rolling out the first two doses of vaccines,” Snape said. “We’re showing … you don’t have to …

December 2, 2021 Omicron coronavirus variant news
3 years ago

December 2, 2021 Omicron coronavirus variant news

CNN  

Dr. Manjul Shukla transfers Pfizer COVID-19 vaccine into a syringe on Thursday, Dec. 2, 2021, at a mobile vaccination clinic in Worcester, Massachusetts. Any one of six different Covid-19 vaccines produce a strong immune system response and should work safely and well as boosters for people who have received initial vaccinations with either the Pfizer/BioNTech or AstraZeneca vaccines, British researchers …

December 2, 2021 Omicron coronavirus variant news
3 years ago

December 2, 2021 Omicron coronavirus variant news

CNN  

Dr. Manjul Shukla transfers Pfizer COVID-19 vaccine into a syringe on Thursday, Dec. 2, 2021, at a mobile vaccination clinic in Worcester, Massachusetts. Any one of six different Covid-19 vaccines produce a strong immune system response and should work safely and well as boosters for people who have received initial vaccinations with either the Pfizer/BioNTech or AstraZeneca vaccines, British researchers …

Mix-and-match vaccines highly effective against COVID-19: Lancet study
3 years, 2 months ago

Mix-and-match vaccines highly effective against COVID-19: Lancet study

Deccan Chronicle  

London: People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study in Sweden. "However, our study shows a greater risk reduction for people who received an mRNA vaccine after having received …

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment
3 years, 2 months ago

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment

News 18  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca asks FDA to authorise COVID antibody treatment
3 years, 2 months ago

AstraZeneca asks FDA to authorise COVID antibody treatment

The Hindu  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca asks FDA to authorize COVID antibody treatment
3 years, 2 months ago

AstraZeneca asks FDA to authorize COVID antibody treatment

LA Times  

AstraZeneca has asked the Food and Drug Administration to authorize the emergency use of an antibody treatment to prevent COVID-19. AstraZeneca, the drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorize the emergency use of a first-of-a-kind antibody treatment to prevent the disease. The Anglo-Swedish company said Tuesday that the …

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial
3 years, 2 months ago

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial

India Today  

AstraZeneca Plc's Covid-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company's US clinical trial published on Wednesday. Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later …

AstraZeneca picks up new vaccine technology originally intended to target Covid
3 years, 3 months ago

AstraZeneca picks up new vaccine technology originally intended to target Covid

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Scientists at Imperial College London are partnering with AstraZeneca to develop …

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary
3 years, 3 months ago

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary

Firstpost  

Oxford University Professor Sarah Gilbert told The Telegraph newspaper that immunity from the vaccine was holding up well — even against the delta variant London: Booster shots to extend the protection of COVID-19 vaccines may be unnecessary for many people, a leading scientist behind the AstraZeneca vaccine said on Friday. Oxford University Professor Sarah Gilbert told The Telegraph newspaper that …

AstraZeneca shot co-creator says recipients 'more likely to get blood clots from COVID than from the vaccine'
3 years, 3 months ago

AstraZeneca shot co-creator says recipients 'more likely to get blood clots from COVID than from the vaccine'

ABC  

Sarah Gilbert is the architect of Oxford University’s AstraZeneca COVID-19 vaccine. Key points: Professor Sarah Gilbert says regular booster shots of COVID-19 vaccines are unlikely to be necessary Professor Sarah Gilbert says regular booster shots of COVID-19 vaccines are unlikely to be necessary She says the AstraZeneca vaccine was created quickly because "we cut out as much of the waiting …

Over 60 and waiting for the Pfizer COVID vaccine? You could die waiting
3 years, 3 months ago

Over 60 and waiting for the Pfizer COVID vaccine? You could die waiting

ABC  

The nation's peak medical body has issued a stark warning: if you're over 60 and are hoping to get the Pfizer COVID-19 jab, you could die waiting. Key points: More than half a million Australians aged between 60 and 69 haven't received a single COVID-19 vaccine dose The Prime Minister has penned a letter urging Australians over 60 to get …

Pfizer COVID-19 jab declines faster than AstraZeneca: study
3 years, 4 months ago

Pfizer COVID-19 jab declines faster than AstraZeneca: study

The Hindu  

The effectiveness of the Pfizer-BioNTech vaccine against COVID-19 declines faster than that of the AstraZeneca jab, according to a new study published on August 19. "Two doses of Pfizer-BioNTech have greater initial effectiveness against new COVID-19 infections, but this declines faster compared with two doses of Oxford-AstraZeneca," researchers at Oxford University said. It found that "the dynamics of immunity following …

AstraZeneca-Sputnik mixing: No breakthrough infection, no serious side effects | Study
3 years, 4 months ago

AstraZeneca-Sputnik mixing: No breakthrough infection, no serious side effects | Study

India Today  

Interim results of the much-awaited study of "vaccine cocktail" are finally out. Heterogenous boosting approach refers to what is called "vaccine cocktail" made using human adenovirus serotype 26 as the first component and human adenovirus serotype 5 as the second component. 'COMBINING DIFFERENT VACCINES KEY TO FIGHT COVID PANDEMIC' After the results of the trials were out, RDIF CEO Kirill …

FDA is letting troubled COVID vaccine factory restart, company says
3 years, 4 months ago

FDA is letting troubled COVID vaccine factory restart, company says

LA Times  

A vial of Johnson & Johnson’s COVID-19 vaccine is used at a pop-up clinic in the Staten Island. The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine, the company said Thursday. The lapses at the Bayview factory have hampered J&J’s efforts to be a major player in …

COVID-19: Are mix-and-match vaccines the way forward?
3 years, 4 months ago

COVID-19: Are mix-and-match vaccines the way forward?

The Hindu  

A new British study confirms reports that a combination of the AstraZeneca and BioNTech vaccines triggers a stronger immune response than two doses of AstraZeneca. Researchers at the University of Oxford have found that patients who received a dose of AstraZeneca followed by a dose of the BioNTech-Pfizer vaccine four weeks later developed a higher number of antibodies than those …

Vaccine inequity: Inside the cutthroat race to secure doses
3 years, 5 months ago

Vaccine inequity: Inside the cutthroat race to secure doses

Associated Press  

PARIS — No one disputes that the world is unfair. “But the whole idea was that we thought rich countries would fund it for the developing world.” Happi said officials never expected the pandemic would strike first and hardest in Europe and the U.S. Or that their assessment of preparedness in the world’s most advanced economies would prove horrifically optimistic. …

A Pfizer dose after one AstraZeneca? Bookings open today
3 years, 5 months ago

A Pfizer dose after one AstraZeneca? Bookings open today

Dutch News  

From Friday, people in the Netherlands who have had one dose of the AstraZeneca vaccine can opt for a second shot of Pfizer/Biontech. The Dutch health council Gezondheidsraad said earlier it sees no objection to people who have had one dose of AstraZeneca having a second shot of the different vaccine because the combination of the two offers good protection …

A Pfizer dose after one AstraZeneca? Bookings open today
3 years, 5 months ago

A Pfizer dose after one AstraZeneca? Bookings open today

Dutch News  

From Friday, people in the Netherlands who have had one dose of the AstraZeneca vaccine can opt for a second shot of Pfizer/Biontech. The Dutch health council Gezondheidsraad said earlier it sees no objection to people who have had one dose of AstraZeneca having a second shot of the different vaccine because the combination of the two offers good protection …

Oxford study says mixing COVID-19 vaccines gives good protection
3 years, 5 months ago

Oxford study says mixing COVID-19 vaccines gives good protection

Deccan Chronicle  

London: Amid the global shortage of the COVID-19 vaccines, a study conducted by Oxford University has found out that alternating doses of the AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against the coronavirus. "The Com-COV study has evaluated 'mix and match' combinations of the Oxford and Pfizer vaccines to see to what extent these vaccines can be used interchangeably, …

AstraZeneca tests Covid booster shots against Beta-variant
3 years, 5 months ago

AstraZeneca tests Covid booster shots against Beta-variant

India TV News  

British-Swedish biopharmaceutical firm AstraZeneca has in partnership with the University of Oxford rolled out human trials for booster shots against Beta Covid variant. The booster shot, named AZD2816, will be administered to individuals who have previously been fully vaccinated with two doses of AstraZeneca vaccine/Vaxzervia or an mRNA vaccine, at least three months after their last injection. AZD2816 has been …

3rd dose of AstraZeneca vaccine after 6 months of second gives strong boost to immunity, says study
3 years, 5 months ago

3rd dose of AstraZeneca vaccine after 6 months of second gives strong boost to immunity, says study

India Today  

A third shot of the Oxford-AstraZeneca Covid-19 vaccine produces a strong immune response, researchers said on Monday, adding there was not yet evidence that such shots were needed, especially given shortages in some countries. The Oxford University study found that a third dose of the vaccine increases antibody and T-cell immune responses, while the second dose can be delayed up …

AstraZeneca Tests Modified Booster Jab Against Beta Variant of Covid-19
3 years, 5 months ago

AstraZeneca Tests Modified Booster Jab Against Beta Variant of Covid-19

News 18  

AstraZeneca and the University of Oxford on Sunday began new trials to test a modified vaccine against the Beta variant, which first emerged in South Africa. The new vaccine, known as AZD2816, has been designed using the same base as the main AstraZeneca shot but with minor genetic alterations to the spike protein based on the Beta variant. “Testing booster …

Rise in Delta variant cases worry UK residents, experts hopeful of AstraZeneca vaccine
3 years, 6 months ago

Rise in Delta variant cases worry UK residents, experts hopeful of AstraZeneca vaccine

India Today  

Real-world data from Public Health England comes as a reassurance against the Delta variant as the number of Covid-19 cases rises in the UK, leading experts to fear the third wave. New real-world data from Public Health England has shown that two doses of AstraZeneca is 92 per cent effective against hospitalisation due to the Delta variant. Mene Pangalos, Executive …

Urgently Trying to Work with AstraZeneca, SII, Indian Govt to Restart Covid-19 Vaccine Shipments: WHO Official
3 years, 6 months ago

Urgently Trying to Work with AstraZeneca, SII, Indian Govt to Restart Covid-19 Vaccine Shipments: WHO Official

News 18  

The WHO is urgently trying to work with AstraZeneca, Serum Institute of India as well as the Indian government to restart shipments of COVID-19 vaccines to countries that had to suspend the rollout of second doses of vaccines amid the disruption in supplies, a senior official at the UN health agency has said. “We have a huge number of countries …

U.S. to spend $ 3.2 billion to develop treatments for COVID-19 and potential threats
3 years, 6 months ago

U.S. to spend $ 3.2 billion to develop treatments for COVID-19 and potential threats

The Hindu  

The United States has announced that it will spend $ 3.2 billion on developing antiviral treatments for COVID-19 and prepare for other “pandemic threats” – viruses that have the potential to cause pandemics. Watch | Dr. Anthony Fauci on the second wave of COVID-19 in India, mucormycosis and more “Vaccines will continue to remain the ‘centrepiece of our arsenal’ against …

We didn’t back govt move to double vaccine dosing gap: scientists
3 years, 6 months ago

We didn’t back govt move to double vaccine dosing gap: scientists

Live Mint  

NEW DELHI : The Indian government doubled the gap between the two doses of the AstraZeneca COVID-19 vaccine without the agreement of the scientific group that it said recommended the increase, three members of the advisory body told Reuters. Gupte, a former director of the state-run National Institute of Epidemiology, said the NTAGI had backed increasing the dosing interval to …

Britain Seeks Extra AstraZeneca Shots to Combat 'Beta' Covid-19 Variant
3 years, 6 months ago

Britain Seeks Extra AstraZeneca Shots to Combat 'Beta' Covid-19 Variant

News 18  

Britain is in talks with Oxford and AstraZeneca for additional doses of their COVID-19 vaccine that has been modified to better target the “beta” coronavirus variant first identified in South Africa, and it will fund trials of the shots. Britain has previously secured 100 million doses of the vaccine, developed at the University of Oxford and licenced to AstraZeneca, and …

Discover Related